Current consensus recommendations for rheumatoid arthritis therapy: A blind spot for osteoporosis prevention and treatment

Journal of Rheumatology

Volumn 29, Issue 9, 2002, Pages 1814-1817

  Jolles, Brigitte M ^a   Bogoch, Earl R ^a  

^a NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; ANTIRHEUMATIC AGENT; CALCITRIOL; CALCIUM; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOPROTEGERIN; RISEDRONIC ACID; SALCATONIN;

CLINICAL TRIAL; DISEASE ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; FRACTURE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MORBIDITY; OSTEOLYSIS; OSTEOPOROSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SYNOVITIS;

ARTHRITIS, RHEUMATOID; COMBINED MODALITY THERAPY; DISEASE MANAGEMENT; FEMALE; HEALTH PLANNING GUIDELINES; HUMANS; INCIDENCE; INTERNATIONAL COOPERATION; MALE; OSTEOPOROSIS; PRIMARY PREVENTION; PROGNOSIS; RISK ASSESSMENT;

EID: 0036735248     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (43)

1. Consensus recommendations for the assessment and treatment of rheumatoid arthritis
2. Overview of current therapies for rheumatoid arthritis
3. Resistant rheumatoid arthritis clinics - A necessary development?
4. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. 2001 update
5. Bisphosphonates for steroid induced osteoporosis
6. Bone abnormalities in the surgical treatment of patients with rheumatoid arthritis
7. Bone loss in rheumatoid arthritis: What role does inflammation play?
8. Generalized bone loss in patients with early rheumatoid arthritis
9. Longitudinal bone mineral density changes in early rheumatoid arthritis
10. Arthritis, not low testosterone, is cause of bone loss in men with active RA
11. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis
12. Bone mineralization and bone mineral metabolism in children with juvenile rheumatoid arthritis
13. Bone mineral status in juvenile rheumatoid arthritis
14. Assessment of bone mineral density in adults with a history of juvenile chronic arthritis. A cross-sectional long-term follow-up study
15. Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland
16. Fractures after rheumatoid arthritis. A population-based study
17. Hip fracture mortality and morbidity - Can we do better?
18. Failure of internal fixation of displaced femoral neck fractures in rheumatoid patients
19. Insufficiency fractures in rheumatic patients: Misdiagnosis and underlying characteristics
20. Bifocal pubic stress fracture after ipsilateral total knee arthroplasty in rheumatoid arthritis. A case report
21. Bone destruction, upward migration, and medialisation of rheumatoid shoulder: A 15 year follow-up study
22. Zoledronate (CGP 42′ 446), a bisphosphonate, protects against metaphyseal intracortical defects in experimental inflammatory arthritis
23. Bone changes in early rheumatoid arthritis
24. Clinical and biochemical response to single infusion of pamidronate in patients with active rheumatoid arthritis: A double blind placebo controlled study
25. Alendronate in rheumatoid arthritis patients treated with methotrexate and glucocorticoids
26. Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patients
27. Intranasal calcitonin for the prevention of bone erosion and bone loss in rheumatoid arthritis
28. Osteoporosis in rheumatoid arthritis - Significance of alfacalcidol in prevention and therapy
29. Calcium and vitamin D supplementation prevents bone loss in the spine secondary to low dose of corticosteroids in patients with rheumatoid arthritis: A randomized, double-blind, placebo controlled trial
30. A randomized controlled clinical trial to compare the efficacy of LY333334 recombinant human parathyroid hormone (1-34) and alendronate sodium in postmenopausal women with osteoporosis
31. Bone loss. Therapeutic approaches for preventing bone loss in inflammatory arthritis
32. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures
33. Changing perceptions in osteoporosis. Markers should be used as adjunct to bone densitometry
34. Should we look for osteoporosis with rheumatoid arthritis?
35. Bone loss. Quantitative imaging techniques for assessing bone mass in rheumatoid arthritis
36. Fractured rheumatoid elbow: Treatment with Souter elbow arthroplasty - A clinical and radiologic midterm follow-up study
37. Fracture threshold of rheumatoid arthritis patients
38. Rheumatoid arthritis, corticoid therapy and hip fracture
39. Intertrochanteric fractures of the femur in rheumatoid arthritis patients
40. Failure of internal fixation of displaced femoral neck fractures in rheumatoid patients
41. Supracondylar fractures of the femur adjacent to resurfacing and MacIntosh arthroplasties of the knee in patients with rheumatoid arthritis
42. Fractures in rheumatoid arthritis: An evaluation of associated risk factors
43. Predictors of fractures in early rheumatoid arthritis